GET THE APP

..

Pharmacoeconomics: Open Access

ISSN: 2472-1042

Open Access

Citations Report

Pharmacoeconomics: Open Access : Citations & Metrics Report

Articles published in Pharmacoeconomics: Open Access have been cited by esteemed scholars and scientists all around the world.

Pharmacoeconomics: Open Access has got h-index 5, which means every article in Pharmacoeconomics: Open Access has got 5 average citations.

Following are the list of articles that have cited the articles published in Pharmacoeconomics: Open Access.

  2022 2021 2020 2019 2018

Total published articles

32 53 7 5 4

Conference proceedings

0 0 0 0 62

Citations received as per Google Scholar, other indexing platforms and portals

21 15 15 10 7
Journal total citations count 95
Journal impact factor 1.2
Journal 5 years impact factor 0.82
Journal cite score 0.78
Journal h-index 5
Journal h-index since 2019 4
Important citations

EFFECT OF THYME (THYMUS VULGARIS) ON PRODUCTIVE PERFORMANCE, CARCASS CHARACTERISTICS, BLOOD HEMATOLOGY AND LIPID PROFILE OF BROILER CHICKS OF BROILER CHICKS

Cost analysis for different sequential treatment regimens for metastatic renal cell carcinoma in China

Factors influencing the variation in GMS prescribing expenditure in Ireland

A Greek Validation Study of the Multiple Sclerosis Work Difficulties Questionnaire-23

RESEARCH AND REVIEWS: JOURNAL OF MEDICAL AND HEALTH SCIENCES

How Cost-of-Illness (COI) Study Provides Direct and Indirect Costs of Multiple Sclerosis (MS) in Bosnia and Herzegovina ?

Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment

Impacto del cambio de presentación del trastuzumab para la Seguridad Social de Costa Rica, estudio de minimización de costos

Primary health care policy and vision for community pharmacy and pharmacists in Portugal

The Challenge of Sustainable Access to Telemonitoring Tools for People with Diabetes in Europe

Cost-Effectiveness of Flash Glucose Monitoring for the Management of Patients with Type 1 and Patients with Type 2 Diabetes in China

The cost-effectiveness of celecoxib versus non-steroidal anti-inflammatory drugs plus proton-pump inhibitors in the treatment of osteoarthritis in Saudi Arabia

Factors influencing the variation in GMS prescribing expenditure in Ireland

A Greek Validation Study of the Multiple Sclerosis Work Difficulties Questionnaire-23.

Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment.

Hypothyroidism in Context: Where We’ve Been and Where We’re Going

A retroductive systems-based methodology for socio-technical transitions research

arrow_upward arrow_upward